The firm says the relocation will enable it to increase capacity to 500 million effervescent tablets per year.
The Aenova Group, one of Europe’s leading manufacturers of solid oral-dosage forms, says it is relocating its manufacturing operations for effervescent products from Bioggio, Switzerland, to Bad Aibling, Germany. The firm says the relocation will enable it to increase capacity to 500 million effervescent tablets per year.
To accommodate the effervescent manufacturing in May next year, the Bad Aibling site is installing two GMP-compliant production lines.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.